Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
765.41-
QQQ
717.38-
BTC/USD
79213.670.9695%
DIA
527.56-
GLD
398.85-
TLT
82.14-

Definium Therapeutics Inc (DFTX) Stock Price, Quote, News & History

DFTXNASDAQ
Trade with Public
Trade with Public
$38.23
At close: Sep 9, 5:00 PM EST
$39.00
0.772.01%
After Hours: 7:12 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Definium Therapeutics (DFTX) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 2.87M
Day Range
- - -
52 Wk Range
14.62 - 49.70
Market Cap
$5.18B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
6.8%
Days to Cover
3.38

Recent Definium Therapeutics Inc News

This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top analysts changed outlook on top names. See analyst ratings page for all changes.
Avi Kapoor

Definium Therapeutics Says Unprecedented Efficacy From Anxiety Study 'Raises the Bar'

Definium Therapeutics says positive Phase 3 trial results for DT120, shows significant and rapid symptom improvement in anxiety participants.
Vandana Singh

Why Is GH Research Stock Trading Higher on Thursday?

GH Research and Definium Therapeutics stocks rose after Eli Lilly agreed to buy AtaiBeckley in a deal worth up to $3.8 billion.
Vandana Singh

Top 3 Health Care Stocks That May Keep You Up At Night In June

Health care stocks flashing warning to momentum investors. RSI indicator shows overbought for DFTX, NRIX, GALT. Check BZ Edge Rankings for more.
Avi Kapoor

Acuity Posts Strong Q3 Results, Joins BlackBerry, MillerKnoll, Qualcomm And Other Big Stocks Moving Higher On Thursday

Dow Jones index gained 200 points; Acuity Inc (NYSE: AYI) reported better-than-expected financial results, shares rose 17.1%; other big stocks also gained.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-167.95M
Investing Cash Flow (TTM)
-224.35M
Financing Cash Flow (TTM)
1.01B
Free Cash Flow (TTM)
-167.95M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
621.89M

Analyst Trends and Forecast

4
Apr
1
May
7
Jun
3
Jul
9
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$4.08B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
5.59
Earnings Yield % (TTM)
-8.98%
Earnings Yield % (FWD)
-4.76%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$6.84

Company Debt

Total Debt
$36.47M
LT Debt
$36.47M
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
$447.00K
Total Cash
$655.27M
Debt to Equity
0.04
Issuance of Debt (TTM)
$447.00K
Repayment of Debt (TTM)
$447.00K

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 2.87M
Day Range
- - -
52 Wk Range
14.62 - 49.70
Market Cap
$5.18B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
6.8%
Days to Cover
3.38

About

Sector
Health Care
Industry
Pharmaceuticals
Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Definium Therapeutics (DFTX) stock?

A

You can purchase shares of Definium Therapeutics (NASDAQ:DFTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Definium Therapeutics (DFTX) competitors?

Q

What is the forecast, or price target, for Definium Therapeutics (DFTX) stock?

A

Definium Therapeutics has a consensus price target of $62.33.

Q

What is the current price for Definium Therapeutics (DFTX)?

A

The stock price for Definium Therapeutics (NASDAQ: DFTX) is $39 last updated September 8, 2026 at 7:12 PM EDT.

Q

Does Definium Therapeutics (DFTX) pay a dividend?

A

There are no upcoming dividends for Definium Therapeutics.

Q

When is Definium Therapeutics (NASDAQ:DFTX) reporting earnings?

A

Definium Therapeutics does not have any upcoming earnings scheduled.

Q

Is Definium Therapeutics (DFTX) going to split?

A

There is no upcoming split for Definium Therapeutics.

Q

What sector and industry does Definium Therapeutics (DFTX) operate in?

A

Definium Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved